Nanexa AB (publ)

kr 9.93As of Sun 8 Nov 2026, 12:00 UTC
STO:NANEXAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 3.75%
Div yield —
ROE 75.91%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.44
PE TTM 12.31
TSR TTM 431.02%
Mkt cap kr 1.897B
ROIC 45.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 10
5.21%
(62.73%)
Hold 2|6|11|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.12
0.12
0.12
0.12
22.21%
16.27%
6.88%
12.03%
Revenuekr M
91.85
90.21
93.55
98.07
(2.91%)
(3.71%)
(0.65%)
6.82%
Peers (US$191.8M)
Cap (US$)
PE
77.47M
731.9x
Capital
TTM
5Y
10Y
Leveragex
0.472
(0.021)
(0.021)
EBIT/Intx
0.953
0.494
0.508
Own earn%
(12.14)
9.95
10.71
Sh yield%
46.42
10.92
13.34
Owners
Insiders/Inst%
10.15
73.55
Short interest%
3.46
SBC / revenue%
2.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
14–27
$1 testx
—
Incr. ROIC%
8